Anticoagulation after stroke: persistent uncertainties.

Siepen, Bernhard M.; Seiffge, David Julian; Fischer, Urs (2022). Anticoagulation after stroke: persistent uncertainties. Current opinion in neurology, 35(1), pp. 55-61. Wolters Kluwer Health 10.1097/WCO.0000000000001009

[img] Text
Siepen__2021__Anticoagulation_after_stroke.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

PURPOSE OF REVIEW

Direct oral anticoagulants (DOAC) are the mainstay of anticoagulant therapy for stroke prevention in patients with nonvalvular atrial fibrillation. Persistent uncertainties remain in different areas, and this review discusses current dilemmas based on selected studies.

RECENT FINDINGS

Optimal timing of DOAC initiation after a recent ischaemic stroke in patients with atrial fibrillation is currently unknown and subject of ongoing randomized controlled trials. Ischaemic stroke despite anticoagulant therapy in patients with atrial fibrillation is frequent, constitutes heterogeneous causes (competing stroke cause, medication error and cardioembolism despite anticoagulation) and optimal treatment is currently unknown. Thorough etiological work-up is justified. Recent randomized controlled trials found no beneficial effect of DOAC therapy in unselected patients with embolic stroke of undetermined source (ESUS). Currently ongoing trials targeting subgroup of ESUS patients with additional atrial cardiopathy will provide novel data. Cerebral mircobleeds combined in a novel risk score (MICON score) provide good predictive value to stratify the risk of intracranial haemorrhage in patients taking anticoagulants. Use of DOAC after intracerebral haemorrhage in patients with atrial fibrillation is subject of ongoing trials.

SUMMARY

There are still significant uncertainties in anticoagulant management in patients with stroke. Ongoing trials will soon provide novel data to improve management of these patients.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

Graduate School:

Graduate School for Health Sciences (GHS)

UniBE Contributor:

Siepen, Bernhard Matthias, Seiffge, David Julian, Fischer, Urs Martin

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1473-6551

Publisher:

Wolters Kluwer Health

Language:

English

Submitter:

Chantal Kottler

Date Deposited:

17 Dec 2021 15:30

Last Modified:

02 Mar 2023 23:35

Publisher DOI:

10.1097/WCO.0000000000001009

PubMed ID:

34812748

BORIS DOI:

10.48350/162038

URI:

https://boris.unibe.ch/id/eprint/162038

Actions (login required)

Edit item Edit item
Provide Feedback